Cargando…
An innovative hematopoietic stem cell gene therapy approach benefits CLN1 disease in the mouse model
Hematopoietic stem and progenitor cells (HSPCs) can establish a long‐lasting microglia‐like progeny in the central nervous system of properly myeloablated hosts. We exploited this approach to treat the severe CLN1 neurodegenerative disorder, which is the most aggressive form of neuronal ceroid lipof...
Autores principales: | Peviani, Marco, Das, Sabyasachi, Patel, Janki, Jno‐Charles, Odella, Kumar, Rajesh, Zguro, Ana, Mathews, Tyler D, Cabras, Paolo, Milazzo, Rita, Cavalca, Eleonora, Poletti, Valentina, Biffi, Alessandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086581/ https://www.ncbi.nlm.nih.gov/pubmed/36876653 http://dx.doi.org/10.15252/emmm.202215968 |
Ejemplares similares
-
Intracerebroventricular delivery of hematopoietic progenitors results in rapid and robust engraftment of microglia-like cells
por: Capotondo, Alessia, et al.
Publicado: (2017) -
Repurposing of tamoxifen ameliorates CLN3 and CLN7 disease phenotype
por: Soldati, Chiara, et al.
Publicado: (2021) -
Data on characterizing the gene expression patterns of neuronal ceroid lipofuscinosis genes: CLN1, CLN2, CLN3, CLN5 and their association to interneuron and neurotransmission markers: Parvalbumin and Somatostatin
por: Minye, Helena M., et al.
Publicado: (2016) -
Glycerophosphoinositol is Elevated in Blood Samples From
CLN3(Δex7-8) pigs,
Cln3(Δex7-8) Mice, and CLN3-Affected
Individuals
por: Brudvig, Jon J, et al.
Publicado: (2022) -
A tailored Cln3(Q352X) mouse model for testing therapeutic interventions in CLN3 Batten disease
por: Langin, Logan, et al.
Publicado: (2020)